Nawar Maher

11PUBLICATIONS
78CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 31, 2026
Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 study.

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|May 13, 2026
Molecular Mechanisms of Resistance to Bispecific Antibodies in Diffuse Large B-Cell Lymphoma.

|Apr 15, 2026
Evolving therapeutic strategies in mantle cell lymphoma: advancements and future directions.

|Sep 13, 2025
Unraveling the Epigenetic Landscape of Mature B Cell Neoplasia: Mechanisms, Biomarkers, and Therapeutic Opportunities.

Nawar Maher, Francesca Maiellaro, Joseph Ghanej

|Jul 08, 2025
Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma.

Riccardo Dondolin, Federico Garrou, Mohammad Almasri

Pageof 2

Frequent Collaborators

9 joint publications

Gianluca Gaidano

6 joint publications

Samir Mouhssine

3 joint publications

Riccardo Moia

3 joint publications

Luca Cividini